Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Ask Dr. Kevin: Debunking the Myths Around Sickle Cell Disease
source: Pfizer Rare Disease in collaboration with the National Newspaper Publishers Association
year: 2017
summary/abstract:This article is the second installment in the “Ask Dr. Kevin” series brought to you by Pfizer Rare Disease in collaboration with the National Newspaper Publishers Association (NNPA) to increase understanding of sickle cell disease.
In the United States, sickle cell disease (SCD) is considered rare because it affects only about 100,000 people nationwide. As such, not many people in the U.S. are aware of what SCD is, or if they are aware, they have limited experience with the disease.
As with any disease, low awareness can spur myths and misperceptions and make it more difficult for those affected to obtain the care and support they need. Throughout my career, I have been asked a number of questions about SCD – many of which are common myths.
In this article, I will share some of the more common myths, in an effort to separate out the facts from fiction.
read more
+myBinderRelated Content
-
The Ways I Made Hydration a HabitWhen I was younger and didn’t have a f...
-
ASH offers early look at updated SCD guidelines: Experts formulated >50 recommendations on sickle cell diseaseThe American Society of Hemato...
-
Clinical, genetic and biological characteristics of hbs_oman: a severe unrevealed form of sickle cell diseaseBackground: Hemoglobin SOman results fro...
-
World sickle cell day 2018 documentaryhttps://www.youtube.com/watch?v=x7fLBl3S...
-
Sickle Cell Trait, Rhabdomyolysis, and Mortality among U.S. Army SoldiersBACKGROUND: Studies have suggested that...
-
MARAC Advisory Statement: Update About COVID-19 VaccinesSeptember 24, 2021 — News about COVID-...
-
Researchers Identify Genetic Predictors of Sickle Cell Anemia-Related ComplicationsPatients with sickle cell anemia who do ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.